These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 18187579

  • 1. Thyroid mimetic as an option for lowering low-density lipoprotein.
    Grundy SM.
    Proc Natl Acad Sci U S A; 2008 Jan 15; 105(2):409-10. PubMed ID: 18187579
    [No Abstract] [Full Text] [Related]

  • 2. The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans.
    Berkenstam A, Kristensen J, Mellström K, Carlsson B, Malm J, Rehnmark S, Garg N, Andersson CM, Rudling M, Sjöberg F, Angelin B, Baxter JD.
    Proc Natl Acad Sci U S A; 2008 Jan 15; 105(2):663-7. PubMed ID: 18160532
    [Abstract] [Full Text] [Related]

  • 3. [Characteristics of fat-lipoid metabolism in experimental athyreosis and hypothyroidism in rats].
    Negovskaia AV.
    Biull Eksp Biol Med; 1972 Jul 15; 73(7):20-2. PubMed ID: 4340125
    [No Abstract] [Full Text] [Related]

  • 4. Phospholipase A2-modified low-density lipoprotein activates macrophage peroxisome proliferator-activated receptors.
    Namgaladze D, Morbitzer D, von Knethen A, Brüne B.
    Arterioscler Thromb Vasc Biol; 2010 Feb 15; 30(2):313-20. PubMed ID: 19948841
    [Abstract] [Full Text] [Related]

  • 5. [Modified low-density lipoprotein].
    Yoshida H, Nakamura H.
    Nihon Rinsho; 1994 Dec 15; 52(12):3090-5. PubMed ID: 7853694
    [Abstract] [Full Text] [Related]

  • 6. Chlamydia pneumoniae induces macrophage-derived foam cell formation via PPAR alpha and PPAR gamma-dependent pathways.
    Mei CL, He P, Cheng B, Liu W, Wang YF, Wan JJ.
    Cell Biol Int; 2009 Mar 15; 33(3):301-8. PubMed ID: 19114110
    [Abstract] [Full Text] [Related]

  • 7. Lipid lowering with thyroid hormone and thyromimetics.
    Angelin B, Rudling M.
    Curr Opin Lipidol; 2010 Dec 15; 21(6):499-506. PubMed ID: 20935564
    [Abstract] [Full Text] [Related]

  • 8. Primate model for the study of hepatic metabolism of lipoprotein cholesterol.
    Redinger RN, Morello A, La Morte WW.
    J Lab Clin Med; 1986 Feb 15; 107(2):103-11. PubMed ID: 3456004
    [Abstract] [Full Text] [Related]

  • 9. The role of human and mouse hepatic scavenger receptor class B type I (SR-BI) in the selective uptake of low-density lipoprotein-cholesteryl esters.
    Rhainds D, Brodeur M, Lapointe J, Charpentier D, Falstrault L, Brissette L.
    Biochemistry; 2003 Jun 24; 42(24):7527-38. PubMed ID: 12809509
    [Abstract] [Full Text] [Related]

  • 10. Serum lipid levels in thyroid dysfunction with special reference to transient elevation during treatment in hyperthyroid Graves' disease.
    Nishitani H, Okamura K, Noguchi S, Inoue K, Morotomi Y, Fujishima M.
    Horm Metab Res; 1990 Sep 24; 22(9):490-3. PubMed ID: 2258137
    [Abstract] [Full Text] [Related]

  • 11. Effects of growth hormone on low-density lipoprotein metabolism.
    Angelin B, Rudling M, Olivecrona H, Ericsson S.
    Acta Paediatr Suppl; 1992 Sep 24; 383():67-8; discussion 69. PubMed ID: 1458020
    [Abstract] [Full Text] [Related]

  • 12. Very low density lipoprotein and low density lipoprotein isolated from patients with hepatitis C infection induce altered cellular lipid metabolism.
    Napolitano M, Giuliani A, Alonzi T, Mancone C, D'Offizi G, Tripodi M, Bravo E.
    J Med Virol; 2007 Mar 24; 79(3):254-8. PubMed ID: 17245726
    [Abstract] [Full Text] [Related]

  • 13. Uptake of low-density lipoprotein by malignant cells--possible therapeutic applications.
    Vitols S.
    Cancer Cells; 1991 Dec 24; 3(12):488-95. PubMed ID: 1840290
    [Abstract] [Full Text] [Related]

  • 14. Effects of oral contraceptives on lipid metabolism.
    Krauss RM.
    J Reprod Med; 1986 Jun 24; 31(6 Suppl):549-50. PubMed ID: 3723487
    [Abstract] [Full Text] [Related]

  • 15. Lipid and lipoprotein metabolism in chronic kidney disease.
    Kaysen GA.
    J Ren Nutr; 2009 Jan 24; 19(1):73-7. PubMed ID: 19121776
    [Abstract] [Full Text] [Related]

  • 16. The low density lipoprotein receptor pathway in animals and man.
    Shepherd J, Packard CJ.
    Health Bull (Edinb); 1982 Jul 24; 40(4):197-205. PubMed ID: 6288622
    [No Abstract] [Full Text] [Related]

  • 17. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK, Bharti BB, Pandey CM, Singh U, Tewari S, Kapoor A, Garg N, Sinha N.
    Indian Heart J; 2003 Jul 24; 55(3):234-40. PubMed ID: 14560932
    [Abstract] [Full Text] [Related]

  • 18. [Lipid risk factors and their role in the pathogenesis of atherosclerosis].
    Vaverková H.
    Vnitr Lek; 1996 Mar 24; 42(3):191-6. PubMed ID: 8686209
    [Abstract] [Full Text] [Related]

  • 19. When the thyroid speaks, the heart listens.
    Sussman MA.
    Circ Res; 2001 Sep 28; 89(7):557-9. PubMed ID: 11577018
    [No Abstract] [Full Text] [Related]

  • 20. The relationship between hepatic low-density lipoprotein receptor activity and serum cholesterol level in the human fetus.
    Cai HJ, Xie CL, Chen Q, Chen XY, Chen YH.
    Hepatology; 1991 May 28; 13(5):852-7. PubMed ID: 2029989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.